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	 Some	novel	imine	derivatives	(1‐14)	of	a	broad	spectrum	antibiotic	amoxicillin	were	prepared
by	condensation	with	different	carbonyl	compounds.	The	amoxicillin	 imine	derivatives	were
characterized	 using	 elemental	 analysis	 and	 spectroscopic	 techniques	 such	 as	 FT‐IR	 and	 1H
NMR.	The	prepared	imine	derivatives	were	evaluated	for	antimicrobial	activities	against	some
pathogens	using	disc	diffusion	method.	The	results	of	present	studies	demonstrate	enhanced
antimicrobial	activity	of	the	novel	imine	derivatives	of	amoxicillin	as	compared	to	the	parent
drug.	
KEYWORDS	
Antibiotics	
Amoxicillin	
Schiff’s	base	
Condensation	
Imine	derivatives	
Antimicrobial	activity	
Cite	this:	Eur.	J.	Chem.	2015,	6(4),	417‐421	
	
1.	Introduction	
	
Antibiotics	 of	 natural	 or	 synthetic	 origin	 have	 an	
enormous	role	in	the	treatment	of	infectious	disease	of	clinical	
importance	 caused	 by	 microorganisms	 [1,2].	 Amoxicillin,	
which	belongs	to	the	class	of	penicillin	is	well‐known	β‐lactam	
antibiotic	 and	 offer	 some	 benefits	 over	 the	 other	 due	 to	
superior	 absorptive	 nature	 (Figure	 1)	 [3].	However	 the	 drug	
efficacy	 get	 diminish	 due	 to	 the	 development	 of	 bacterial	
resistance.	 To	 overcome	 such	 resistance	 minor	 chemical	
modifications	were	performed	with	the	drug	to	convert	 them	
into	 pro‐drugs.	 Major	 chemical	 modifications	 can	 possibly	
alter	 or	 weaken	 the	 entire	 drug	 activity.	 β‐lactam	 drugs	 are	
usually	obtained	from	fungi	or	molds	[4].	Though	most	of	the	
β‐lactam	antibiotics	are	active	against	gram	positive	bacteria,	
yet	there	are	some	recently	developed	drug	like	cephalosporin	
[5]	etc.	which	serve	as	broad	spectrum	antibiotics	both	against	
gram	positive	and	gram	negative	bacteria	[6,7].	Prominence	of	
amoxicillin	 in	 research	 studies	 associated	 to	 pharmaceutical	
and	 biologically	 active	 zones	 has	 been	 increased	 in	 current	
years	[8,9].		
Literature	 showed	 that	 imine	derivatives	of	drugs	exhibit	
the	same	or	more	potency,	but	have	advantages	 to	overcome	
the	issues	of	drug	resistance	in	medicinal	chemistry.	The	pro‐
drugs	 encompassing	 imine	 linkage	 in	 their	 structural	
framework	 have	 been	 described	 as	 antibacterial,	 antifungal	
and	antiviral	etc.	[10,11].	
	
 
	
Figure	1. Amoxicillin	trihydrate,	I.	
	
As	 the	 extensive	 use	 of	 antibiotics	 lead	 to	 severe	 drug	
resistant	 complications,	 so	 to	 minimize	 such	 problems	 drug	
modification	 has	 gain	 much	 attention	 from	 chemists	 and	
pharmacologists.	Tomi	et	al.	synthesized	some	Schiff	base	type	
compounds	 derived	 from	 amoxicillin	 and	 reported	 their	
boosted	biological	activity	in	the	fresh	studies	[12].	Joshi,	S.	et	
al.	 synthesized	 certain	 new	 Schiff	 bases	 derived	 from	
amoxicillin	 trihydrate	 with	 cinnamaldehyde	 and	 p‐chloro	
benzaldehyde	and	described	their	antibacterial	activity	[13].		
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Scheme	1	
	
	
Metal	complexes	with	the	amoxicillin	derivatives	were	also	
synthesized	 [14,15].	 	 Copper,	 Cobalt	 and	 Zinc	 chloride	 salts	
were	 used	 for	 metal	 complexation.	 It	 was	 found	 that	 novel	
Schiff	 bases	 were	 found	 to	 be	 having	 better	 antibacterial	
activity	 as	 compared	 to	 the	 parent	 amoxicillin.	 Antibacterial	
potential	 has	 also	 been	 investigated	 using	 chalcone	 based	
heterocycles	[16]	while	some	xantnone	derivatives	have	been	
reported	 as	 antitumor,	 antimicrobial,	 anti‐oxidant,	 anti‐
allergic	 agents	 etc.	 [17].	 Very	 recently,	we	 have	 reported	 the	
synthesis	of	novel	xanthene	based	 imine	derivatives	showing	
excellent	 antibacterial	 activity	 [18].	 Inspired	 with	 biological	
activities	 possessed	 by	 imines	 [19‐23]	 and	 amoxicillin,	 an	
endeavor	 was	 made	 to	 manufacture	 novel	 imine	 derivatives	
(1‐14)	of	amoxicillin	by	condensing	it	with	different	aldehydes	
and	 ketones.	 The	 novel	 amoxicillin	 imine	 derivatives	 were	
characterized	well	 by	 different	 spectroscopic	 techniques	 and	
screened	for	antimicrobial	activities.	
	
2.	Experimental		
	
2.1.	Materials	and	methods	
	
Amoxicillin	 trihydrate	 was	 obtained	 from	 a	 company	
based	 in	 china.	Aldehydes	 and	ketones	were	purchased	 from	
Sigma	 Aldrich.	 Absolute	 ethanol	 was	 purchased	 from	Merck.	
Thin	 Layer	 Chromatography	 (TLC)	 to	 monitor	 reaction	
progress	was	performed	with	silica	gel	60,	0.063‐0.200	mm	as	
the	 stationary	 phase	 with	 analytical	 grad	 solvents.	 Melting	
points	 of	 compounds	 were	 obtained	 from	 Electro	 thermal	
apparatus.	For	elemental	analysis,	Euro‐Vector	model	EA	3000	
instrument	was	used.	Shimadzu	model	FT‐IR‐8400S	was	used	
for	 FT‐IR	 spectra.	 BRUKER	 model	 Ultra	 shield	 300	 MHz	
spectrophotometer	was	used	for	 1H	NMR	spectra	 in	DMSO‐d6	
solution	with	TMS	taken	as	internal	standard.	
	
2.2.	General	synthetic	layout	for	amoxicillin	imine	
derivatives	(1‐14)		
	
The	 novel	 imine	 derivatives	 were	 synthesized	 by	
condensing	 the	 amoxicillin	 trihydrate	 and	 different	 carbonyl	
compounds.	 In	 typical	 reaction,	 the	 corresponding	 aldehydes	
of	ketones	(1.0	mmol)	were	mixed	with	amoxicillin	trihydrate	
(0.419	g,	1.0	mmol)	in	absolute	ethanol.	The	resulting	mixture	
was	heated	at	reflux	for	6	to	14	h.	The	solution	obtained	after	
reaction	completion	was	 transferred	 into	cold	water	 (60	mL)	
which	 resulted	 in	 immediate	 precipitation	 of	 the	
corresponding	 imine	 derivative.	 The	 precipitates	 were	
collected,	washed	 several	 times	with	 cold	water,	 dried	under	
vacuum	and	kept	in	a	desiccators	[12,13]	(Scheme	1,	Table	1).		
(2S,5R,6R)‐6‐(2‐((Z)‐(4‐Acetamidobenzylidene)amino)‐2‐(4‐
hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐aza	
bicycle[3.2.0]heptane‐2‐carboxylic	 acid	 (1):	 Color:	 Yellow	
powder.	 Yield:	 78%.	 M.p.:	 260‐262	 °C.	 Rf	 =	 0.26	 (Petroleum	
ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1662.	 1H	 NMR	 (300	
MHz,	DMSO‐d6,	 δ,	 ppm):	11.01	 (brs,	 1H,	COOH),	10.09	 (s,	 1H,	
CH=N),	 9.09	 (s,	 1H,	 OH),	 8.1	 (s,	 1H,	 CO‐NH‐Ar),	 8.61	 (d,	 1H,	
NH),	7.71	(m,	2H,	Ar‐H),	7.34	(d,	J	=	7.2	Hz,	2H,	Ar‐Hb),	6.9	(m,	
2H,	Ar‐H),	6.72	(d,	J	=	7.2	Hz,	2H,	Ar‐Ha),	5.55	(brs,	1H,	CH‐S),	
5.28	 (d,	1H,	N‐CH‐CO),	4.89	 (s,	1H,	CH‐N=C),	3.99	 (s,	1H,	CH‐
COOH),	2.01	(s,	3H,	CH3CON),	1.48	(s,	3H,	B‐CH3),	1.34	(s,	3H,	
A‐CH3).	Anal.	calcd.	for	C25H26N4O6S:	C,	58.81;	H,	5.13;	N,	10.97.	
Found:	C,	58.52;	H,	5.06;	N,	10.75%.	
(2S,5R,6R)‐6‐(2‐(((E)‐2‐Bromo‐1‐(4‐nitrophenyl)ethylidene)	
amino)‐2‐(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐
thia‐1‐azabicyclo[3.2.0]heptane‐2‐carboxylic	 acid	 (2):	 Color:	
Dark	 brown	 powder.	 Yield:	 86%.	M.p.:	 248‐250	 °C.	 Rf	 =	 0.31	
(petroleum	ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	,	 cm‐1):	 1664.	 1H	
NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	11.08	(brs,	1H,	COOH),	9.01	
(d,	s,	1H,	OH),	8.74	(d,	1H,	NH),	8.32	(m,	2H,	Ar‐H),	7.81	(m,	2H,	
Ar‐H),	7.33	(d,	J=	7.2	Hz,	2H,	Ar‐Hb),	6.73	(d,	J=	7.2	Hz,	2H,	Ar‐
Ha),	5.7	(s,	2H,	CH2Br),	5.52	(brs,	1H,	CH‐S),	5.29	(d,	1H,	N‐CH‐
CO),	4.8	(s,	1H,	CH‐N=C),	3.95	(s,	1H,	CH‐COOH),	1.47	(s,	3H,	B‐
CH3),	 1.32	 (s,	 3H,	 A‐CH3).	 Anal.	 calcd.	 for	 C24H23N4O7BrS:	 C,	
48.74;	H,	3.92;	N,	9.47.	Found:	C,	48.65;	H,	4.02;	N,	9.39%.	
(2S,	 5R,	 6R)‐6‐(2‐(((E)‐1‐(2‐Hydroxyphenyl)ethylidene)ami	
no)‐2‐(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐
1‐azabicyclo[3.2.0]heptane‐2‐carboxylic	acid	(3):	Color:	Yellow	
powder.	 Yield:	 74%.	 M.p.:	 258‐260	 °C.	 Rf	 =	 0.30	 (petroleum	
ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1663.	 1H	 NMR	 (300	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 11.06	 (brs,	 1H,	 COOH),	 9.08	 (s,	 1H,	
OH),	9.04	(s,	1H,	OH),	8.63	(d,	1H,	NH),	7.32‐7.21	(m,	4H,	Ar‐H,	
Ar‐Hb),	6.91	(dd,	 J	=	7.8	Hz,	1.89	Hz,	1H,	Ar‐H),	6.77‐6.73	(m,	
3H	Ar‐H,	Ar‐Ha),	5.57	 (brs,	1H,	CH‐S),	 5.31	 (d,	1H,	N‐CH‐CO),	
4.86	 (s,	1H,	CH‐N=C),	3.97	 (s,	 1H,	CH‐COOH),	2.3	 (s,	3H,	CH3‐
C=N),	1.53	 (s,	3H,	B‐CH3),	1.39	(s,	3H,	A‐CH3).	Anal.	 calcd.	 for	
C24H25N3O6S:	C,	59.61;	H,	5.21;	N,	8.69.	Found:	C,	59.73;	H,	5.33;	
N,	8.81%.	
(2S,5R,6R)‐6‐(2‐(((E)‐5,	 6‐Dimethoxy‐2,3‐dihydro‐1H‐inden‐
1‐ylidene)amino)‐2‐(4‐hydroxyphenyl)acetamido)‐3,3‐dimethyl‐
7‐oxo‐4‐thia‐1‐azabicyclo[3.2.0]heptane‐2‐carboxylic	 acid	 (4):	
Color:	Yellow	powder.	Yield:	69%.	M.p.:	255‐257	°C.	Rf	=	0.34	
(petroleum	ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	,	 cm‐1):	 1662.	 1H	
NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	11.01	(brs,	1H,	COOH),	9.10	
(s,	 1H,	OH),	 8.69	 (d,	 1H,	NH),	7.33	 (d,	 J	=	7.2	Hz,	2H,	Ar‐Hb),	
6.73	(d,	 J	=	7.2	Hz,	2H,	Ar‐Ha),	6.63	(s,	1H,	Ar‐H),	6.52	(s,	1H,	
Ar‐H),	5.48	(brs,	1H,	CH‐S),	5.31	(d,	1H,	N‐CH‐CO),	4.82	(s,	1H,	
CH‐N=C),	 3.93	 (s,	 1H,	 CH‐COOH),	 3.81	 (s,	 3H,	 OCH3),	 3.79	 (s,	
3H,	OCH3),	2.78	(t,	2H,	J	=	4.5	Hz,	CH2‐C=N),	1.75	(t,	2H,	J	=	4.5	
Hz,	CH2‐cyclopentyl),	 1.46	 (s,	 3H,	B‐CH3),	 1.37	 (s,	 3H,	A‐CH3).	
Anal.	calcd.	 for	C27H29N3O7S:	C,	60.10;	H,	5.42;	N,	7.79.	Found:	
C,	60.22;	H,	5.65;	N,	7.93%.	
(2S,	 5R,	 6R)‐6‐(2‐(((E)‐(1H‐Indol‐3‐yl)methylene)amino)‐2‐
(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐aza	
bicyclo[3.2.0]heptane‐2‐carboxylic	acid	(5):	Color:	Red	powder.	
Yield:	 88%.	 M.p.:	 281‐283	 °C.	 Rf	 =	 0.29	 (petroleum	 ether:	
CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1662.	 1H	 NMR	 (300	 MHz,	
DMSO‐d6,	δ,	ppm):	11.86	(brs,	1H,	 indole‐NH),	11.08	(brs,	1H,	
COOH),	9.35	(s,	1H,	CH=N),	9.05	(s,	1H,	OH),	8.67	(d,	1H,	NH),	
8.44	(dd,	 J	=	7.5	Hz,	1.8	Hz,	1H,	 indole‐H),	8.15	(d,	 J	=	7.9	Hz,	
1H,	indole‐H),	7.36	(d,	J	=	7.2	Hz,	2H,	Ar‐Hb),	7.29‐7.10	(m,	3H,	
indole‐H),	6.77	(d,	J	=	7.2	Hz,	2H,	Ar‐Ha),	5.56	(brs,	1H,	CH‐S),	
5.30	 (d,	1H,	N‐CH‐CO),	4.87	 (s,	1H,	CH‐N=C),	3.94	 (s,	1H,	CH‐
COOH),	1.48	(s,	3H,	B‐CH3),	1.33	(s,	3H,	A‐CH3).	Anal.	calcd.	for	
C25H24N4O5S:	 C,	 60.96;	 H,	 4.91;	 N,	 11.37.	 Found:	 C,	 61.09;	 H,	
5.15;	N,	11.59%.	
(2S,5R,6R)‐6‐(2‐(((E)‐1‐(Benzofuran‐2‐yl)ethylidene)amino)	
‐2‐(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐
azabicyclo	[3.2.0]	heptane‐2‐carboxylic	acid	(6):	Color:	Yellow		
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Table	1.	Amoxicillin	imine	derivatives	1‐14.	
 
	
Compounds	 Yield	(%)	 Compounds	 Yield	(%)	
1	
	
78 8 68	
2	 R1 = CH2 Br
NO2R2 =
	
86	 9	
	
62	
3	
	
74 10 87	
4	
	
69	 11	 90	
5	
	
88 12
	
75	
6	
	
71	 13	 83	
7	
	
82	 14	 76	
	
	
powder.	 Yield:	 71%.	 M.p.:	 271‐273	 °C.	 Rf	 =	 0.31	 (petroleum	
ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1665.	 1H	 NMR	 (300	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 11.09	 (brs,	 1H,	 COOH),	 9.09	 (s,	 1H,	
OH),	 8.72	 (d,	 1H,	 NH),	 8.41	 (dd,	 J	 =	 7.3	 Hz,	 1.9	 Hz,	 1H,	
benzofuran‐H),	8.16	(d,	J	=	7.8	Hz,	1H,	benzofuran	‐H),	7.36	(d,	
J	=	7.2	Hz,	2H,	Ar‐Hb),	7.29‐7.1	(m,	3H,	benzofuran	‐H),	6.75	(d,	
J	=	7.2	Hz,	2H,	Ar‐Ha),	5.46	(brs,	1H,	CH‐S),	5.27	(d,	1H,	N‐CH‐
CO),	 4.85	 (s,	 1H,	 CH‐N=C),	 3.97	 (s,	 1H,	 CH‐COOH),	 2.7	 (s,	 3H,	
CH3‐C=N),	1.50	(s,	3H,	B‐CH3),	1.38	(s,	3H,	A‐CH3).	Anal.	calcd.	
for	C26H25N3O6S:	C,	61.53;	H,	4.96;	N,	8.28.	Found:	C,	61.37;	H,	
5.12;	N,	8.50%.	
(2S,	 5R,	 6R)‐6‐(2‐(4‐Hydroxyphenyl)‐2‐(((E)‐(5‐methylthio	
phen‐2‐yl)methylene)amino)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐
thia‐1‐azabicyclo[3.2.0]heptane‐2‐carboxylic	 acid	 (7):	 Color:	
Brown	powder.	Yield:	82%.	M.p.:	272‐274	°C.	Rf	=	0.30	(petro‐
leum	 ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1663.	 1H	NMR	
(300	MHz,	DMSO‐d6,	δ,	ppm):	11.05	(brs,	1H,	COOH),	10.03	(s,	
1H,	CH=N),	9.08	(s,	1H,	OH),	8.74	(d,	1H,	NH),	6.91	(d,	 J	=	8.2	
Hz,	 1H,	 thiophene‐H),	 6.72	 (d,	 J	 =	 8.2	 Hz,	 1H,	 thiophene‐H),	
7.32	(d,	J	=	7.4	Hz,	2H,	Ar‐Hb),	6.70	(d,	J	=	7.4	Hz,	2H,	Ar‐Ha),	
5.50	 (brs,	 1H,	 CH‐S),	 5.36	 (d,	 1H,	N‐CH‐CO),	 4.80	 (s,	 1H,	 CH‐
N=C),	3.96	(s,	1H,	CH‐COOH),	2.55	(s,	3H,	CH3‐thiophene),	1.47	
(s,	 3H,	 B‐CH3),	 1.36	 (s,	 3H,	 A‐CH3).	 Anal.	 calcd.	 for	
C22H23N3O5S2:	 C,	 55.80;	 H,	 4.90;	 N,	 8.87.	 Found:	 C,	 55.98;	 H,	
5.09;	N,	9.07%.	
(2S,	 5R,	 6R)‐6‐(2‐(4‐Hydroxyphenyl)‐2‐(((E)‐(3‐methylthio	
phen‐2‐yl)methylene)amino)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐
thia‐1‐azabicyclo[3.2.0]	 heptane‐2‐carboxylic	 acid	 (8):	 Color:	
Green	 powder.	 Yield:	 68%.	 M.p.:	 257‐259	 °C.	 Rf	 =	 0.29	
(petroleum	ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	,	 cm‐1):	 1664.	 1H	
NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 11.08	 (brs,	 1H,	 COOH),	
10.11	(s,	1H,	CH=N),	9.06	(s,	1H,	OH),	8.65	(d,	1H,	NH),	7.23	(d,	
J	=	7.5	Hz,	1H,	thiophene‐H),	6.72	(d,	J	=	7.5	Hz,	1H,	thiophene‐
H),	7.31	(d,	 J	=	7.3	Hz,	2H,	Ar‐Hb),	6.71	(d,	J	=	7.3	Hz,	2H,	Ar‐
Ha),	 5.52	 (brs,	 1H,	 CH‐S),	 5.35	 (d,	 1H,	N‐CH‐CO),	 4.83	 (s,	 1H,	
CH‐N=C),	3.90	 (s,	1H,	CH‐COOH),	2.54	 (s,	3H,	CH3‐thiophene),	
1.51	 (s,	 3H,	 B‐CH3),	 1.33	 (s,	 3H,	 A‐CH3).	 Anal.	 calcd.	 for	
C22H23N3O5S2:	 C,	 55.80;	 H,	 4.90;	 N,	 8.87.	 Found:	 C,	 55.96;	 H,	
5.11;	N,	9.05%.	
(2S,	 5R,	 6R)‐6‐(2‐(((E)‐Furan‐2‐ylmethylene)amino)‐2‐
(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐
azabicyclo[3.2.0]	 heptane‐2‐carboxylic	 acid	 (9):	 Color:	 Dark	
grey	 powder.	 Yield:	 62%.	M.p.:	 262‐264	 °C.	 Rf	 =	 0.37	 (petro‐
leum	 ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	,	 cm‐1):	 1661.	 1H	NMR	
(300	MHz,	DMSO‐d6,	δ,	ppm):	11.09	(brs,	1H,	COOH),	10.10	(s,	
1H,	CH=N),	9.04	(s,	1H,	OH),	8.66	(d,	1H,	NH),	7.31	(d,	J	=	7.31	
Hz,	2H,	Ar‐Hb),	7.21	(dd,	J	=	8.5	Hz,	2.1	Hz,	1H,	furan‐H),	6.76	
(d,	J	=	7.3	Hz,	2H,	Ar‐Ha),	6.2‐6.01	(m,	2H,	furan‐H),	5.59	(brs,	
1H,	CH‐S),	5.32	(d,	1H,	N‐CH‐CO),	4.85	(s,	1H,	CH‐N=C),	3.90	(s,	
1H,	 CH‐COOH),	 1.49	 (s,	 3H,	B‐CH3),	 1.35	 (s,	 3H,	 A‐CH3).	 Anal.	
calcd.	 for	 C21H21N3O6S:	 C,	 56.87;	 H,	 4.77;	 N,	 9.48.	 Found:	 C,	
56.79;	H,	4.62;	N,	9.64%.	
(2S,	5R,	6R)‐6‐(2‐(4‐Hydroxyphenyl)‐2‐(((E)‐3‐methyl‐4‐oxo	
naphthalen‐1(4H)‐ylidene)amino)acetamido)‐3,	 3‐dimethyl‐7‐
oxo‐4‐thia‐1‐azabicyclo[3.2.0]	 heptane‐2‐carboxylic	 acid	 (10):	
Color:	Brown	powder.	Yield:	87%.	M.p:	290‐292	 °C.	Rf	=	0.33	
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(petroleum	ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	,	 cm‐1):	 1666.	 1H	
NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	11.07	(brs,	1H,	COOH),	9.05	
(s,	1H,	OH),	8.69	(d,	1H,	NH),	8.05‐7.77	(m,	4H,	Ar‐H),	7.33	(d,	J	
=	7.51	Hz,	2H,	Ar‐Hb),	6.8	(s,	1H,	CH‐C=N),	6.72	(d,	J	=	7.5	Hz,	
2H,	Ar‐Ha),	5.51	(brs,	1H,	CH‐S),	5.29	(d,	1H,	N‐CH‐CO),	4.88	(s,	
1H,	 CH‐N=C),	 4.01	 (s,	 1H,	 CH‐COOH),	 2.20	 (s,	 3H,	 CH3‐C=C),	
1.43	 (s,	 3H,	 B‐CH3),	 1.40	 (s,	 3H,	 A‐CH3).	 Anal.	 calcd.	 for	
C27H25N3O6S:	C,	62.41;	H,	4.85;	N,	8.09.	Found:	C,	62.59;	H,	5.01;	
N,	8.32%.	
(2S,5R,	 6R)‐6‐(2‐(((E)‐(1H‐Pyrrol‐2‐yl)methylene)amino)‐2‐
(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐aza	
bicyclo[3.2.0]	 heptane‐2‐carboxylic	 acid	 (11):	 Color:	 Silvery	
powder.	 Yield:	 90%.	 M.p.:	 243‐245	 °C.	 Rf	 =	 0.38	 (petroleum	
ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1662.	 1H	 NMR	 (300	
MHz,	DMSO‐d6,	 δ,	 ppm):	11.09	 (brs,	 1H,	COOH),	10.04	 (s,	 1H,	
CH=N),	 9.08	 (s,	 1H,	 OH),	 8.70	 (d,	 1H,	 NH),	 7.81	 (s,	 1H,	 NH‐
pyrrole),	7.30	(d,	J	=	7.51	Hz,	2H,	Ar‐Hb),	7.25	(dd,	 J	=	8.1	Hz,	
2.0	Hz,	1H,	pyrrole‐H),	6.71	(d,	J	=	7.5	Hz,	2H,	Ar‐Ha),	6.5‐6.21	
(m,	2H,	pyrrole‐H),	5.55	(brs,	1H,	CH‐S),	5.36	(d,	1H,	N‐CH‐CO),	
4.89	 (s,	 1H,	 CH‐N=C),	 3.98	 (s,	 1H,	 CH‐COOH),	 1.45	 (s,	 3H,	 B‐
CH3),	1.36	(s,	3H,	A‐CH3).	Anal.	calcd.	for	C21H22N4O5S:	C,	57.00;	
H,	5.01;	N,	12.66.	Found:	C,	57.28;	H,	5.40;	N,	12.77%.	
(2S,5R,6R)‐6‐(2‐(((E)‐1‐(4‐Bromophenyl)ethylidene)	amino)	
‐2‐(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐
azabicyclo[3.2.0]	heptane‐2‐carboxylic	acid	 (12):	 Color:	Bright	
Yellow	powder.	Yield:	75%.	M.p.:	270‐272	°C.	Rf	=	0.32	(petro‐
leum	 ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1665.	 1H	NMR	
(300	MHz,	DMSO‐d6,	 δ,	ppm):	11.06	 (brs,	1H,	COOH),	9.12	 (s,	
1H,	OH),	8.72	(d,	1H,	NH),	8.02	(m,	2H,	Ar‐H),	7.71	(m,	2H,	Ar‐
H),	7.28	(d,	 J	=	7.9	Hz,	2H,	Ar‐Hb),	6.71	(d,	 J	=	7.9	Hz,	2H,	Ar‐
Ha),	 5.52	 (brs,	 1H,	 CH‐S),	 5.31	 (d,	 1H,	N‐CH‐CO),	 4.81	 (s,	 1H,	
CH‐N=C),	3.96	(s,	1H,	CH‐COOH),	2.5	(s,	3H,	CH3‐C=N),	1.46	(s,	
3H,	B‐CH3),	1.37	(s,	3H,	A‐CH3).	Anal.	calcd.	for	C24H24BrN3O5S:	
C,	52.75;	H,	4.43;	N,	7.69.	Found:	C,	52.96;	H,	4.45;	N,	7.89%.	
(2S,5R,6R)‐6‐(2‐(((E)‐1‐(4‐Fluorophenyl)ethylidene)amino)‐
2‐(4‐hydroxyphenyl)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐
azabicyclo[3.2.0]	heptane‐2‐carboxylic	acid	(13):	Color:	Cream	
yellow	powder.	Yield:	83%.	M.p.:	258‐260	°C.	Rf	=	0.29	(petro‐
leum	 ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1665.	 1H	NMR	
(300	MHz,	DMSO‐d6,	 δ,	ppm):	11.05	 (brs,	1H,	COOH),	9.04	 (s,	
1H,	OH),	8.69	(d,	1H,	NH),	8.12	(m,	2H,	Ar‐H),	7.91	(m,	2H,	Ar‐
H),	7.29	(d,	 J	=	7.5	Hz,	2H,	Ar‐Hb),	6.66	(d,	 J	=	7.5	Hz,	2H,	Ar‐
Ha),	 5.48	 (brs,	 1H,	 CH‐S),	 5.35	 (d,	 1H,	N‐CH‐CO),	 4.90	 (s,	 1H,	
CH‐N=C),	3.99	(s,	1H,	CH‐COOH),	2.47	(s,	3H,	CH3‐C=N),	1.54	(s,	
3H,	B‐CH3),	1.34	(s,	3H,	A‐CH3).	Anal.	 calcd.	 for	C24H24FN3O5S:	
C,	59.37;	H,	4.98;	N,	8.65.	Found:	C,	59.53;	H,	5.09;	N,	8.42%.	
(2S,5R,6R)‐6‐(2‐(4‐Hydroxyphenyl)‐2‐(((Z)‐2‐oxoindolin‐3‐
ylidene)amino)acetamido)‐3,	 3‐dimethyl‐7‐oxo‐4‐thia‐1‐aza	
bicyclo[3.2.0]heptane‐2‐carboxylic	 acid	 (14):	 Color:	 Dark	 grey	
powder.	 Yield:	 76%.	 M.p.:	 279‐281	 °C.	 Rf	 =	 0.30	 (petroleum	
ether:	 CH2Cl2,	 2:1).	 FT‐IR	 (KBr,	 ,	 cm‐1):	 1666.	 1H	 NMR	 (300	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 11.07	 (brs,	 1H,	 COOH),	 11.0	 (s,	 1H,	
NH‐isatin),	9.08	(s,	1H,	OH),	8.71	(d,	1H,	NH),	8.44	(dd,	J	=	7.9	
Hz,	1.8	Hz,	1H,	isatin‐H),	8.15	(d,	J	=	7.89	Hz,	1H,	isatin‐H),	7.39	
(d,	J	=	7.8	Hz,	2H,	Ar‐Hb),	7.28	(m,	2H,	isatin‐H),	6.68	(d,	J	=	7.8	
Hz,	 2H,	 Ar‐Ha),	 5.49	 (brs,	 1H,	 CH‐S),	 5.33	 (d,	 1H,	 N‐CH‐CO),	
4.87	 (s,	 1H,	 CH‐N=C),	 3.92	 (s,	 1H,	 CH‐COOH),	 1.52	 (s,	 3H,	 B‐
CH3),	1.41	(s,	3H,	A‐CH3).	Anal.	calcd.	for	C24H22N4O6S:	C,	58.29;	
H,	4.48;	N,	11.33.	Found:	C,	58.52;	H,	4.60;	N,	11.53%.	
	
2.3.	In	vitro	antimicrobial	studies		
	
Amoxicillin	was	 used	 in	 different	 concentrations	 (1×10‐1,	
1×10‐3,	 1×10‐5	 and	 1×10‐7	M)	 as	 a	 standard	 antimicrobial.	 All	
the	 synthetic	 derivatives	 (1‐14)	 were	 screened	 for	
antimicrobial	 activities	 using	 disc	 diffusion	 method	 by	
measuring	 the	 inhibition	 zone	 in	 comparison	 with	 the	
standard	 drug,	 amoxicillin.	 Antimicrobial	 activity	 of	 the	
compounds	was	determined	against	bacterial	strains	including	
Staphylococcus	 epidermidis,	 Pseudomonas	 aeruginosa,	
Escherichia	 coli	 which	 were	 isolated	 from	 urinary	 tract	
infections,	 surgical	 theaters,	 nose	 swab	 and	 infected	wounds	
respectively	in	Muller	Hinton	agar.	These	sterilized	agar	media	
were	 transferred	 to	 petri‐dishes	 and	 allowed	 to	 solidify.	
Microbial	suspensions	were	spread	on	the	surface	of	the	media	
with	 sterilized	 triangular	 loop.	 A	 pre‐sterilized	 stainless	
cylinder	having	12	mm	diameter	was	used	to	bore	the	cavities.	
The	 amoxicillin	 imine	 derivatives	 of	 various	 concentration	
(1×10‐1,	 1×10‐3,	 1×10‐5	 and	 1×10‐7	 M)	 were	 placed	 in	 the	
cavities	using	a	micropipette	and	allowed	to	de	diffused	for	1	
h.	 DMSO	 was	 used	 as	 a	 solvent	 for	 all	 the	 synthetic	 imine	
derivatives	 while	 sterile	 distilled	 water	 was	 used	 for	 pure	
amoxicillin.	 These	 plates	were	 incubated	 at	 370	 °C	 for	 48	 h.	
The	 inhibition	 zone	 was	 measured	 in	 mm	 around	 the	 cups	
after	respective	incubation.	
	
3.	Results	and	discussion	
	
3.1.	Chemistry	
	
The	 synthetic	 layout	 of	 the	 amoxicillin	 imine	 derivatives	
has	 been	 presented	 in	 the	 Scheme	 1.	 Commercially	 available	
amoxicillin	 trihydrate	 was	 coupled	 with	 different	 carbonyl	
compounds	 in	 absolute	 ethanol	 as	 solvent.	 The	 reaction	
mixtures	were	 poured	 in	 cold	water	 to	 afford	precipitates	 of	
the	 imine	derivative	(1‐14).	The	progress	of	the	reaction	was	
monitored	 by	 thin	 layer	 chromatography	 until	 the	 complete	
consumption	 of	 starting	 material.	 All	 the	 novel	 compounds	
were	 characterized	 by	 different	 spectroscopic	 techniques.	
Physical	parameters	 including	color,	 solubility,	melting	point,	
elemental	 analysis	were	 also	 determined.	 Elemental	 analysis	
data	confirms	the	expected	molar	mass	and	formation	of	new	
compounds.	 FT‐IR	 spectroscopic	 data	 in	 which	 the	 bands	
(1661‐1666	 cm‐1)	 indicate	 clearly	 the	 presence	 of	 CH=N	
function.	 Conversion	 of	 NH2	 group	 of	 amoxicillin	 to	 imine	
linkage	CH=N	is	confirmed	by	the	disappearance	of	two	bands	
at	 (3332	 and	 3163	 cm‐1)	 which	 could	 be	 attributed	 to	
symmetric	 and	 asymmetric	 stretching	 of	 NH2	 group	 of	
amoxicillin.	1H	NMR	data	of	amoxicillin	derivatives	in	DMSO‐d6	
solvent	has	been	provided	in	the	experimental	section.		
	
3.2.	Bioactivity	
	
Novel	 amoxicillin	 imine	 compounds	 (1‐14)	 have	 been	
screened	 for	 in	 vitro	 antimicrobial	 or	 antibacterial	 activities	
(Table	 2).	 Examining	 the	 data	 of	 inhibition	 zone	 against	
Pseudomonas	aeruginosa,	it	is	observed	that	almost	all	the	new	
compounds	 showed	 antibacterial	 activities	 more	 than	 the	
parent	 drug	 amoxicillin.	 The	 bioactivity	 increases	 with	
increasing	 the	 concentration	 of	 the	 compounds.	 Imine	
derivatives	of	amoxicillin	with	carbonyl	compounds	5,	6,	9,	10,	
11,	 12	 and	 13	 showed	 remarkable	 activity	 against	
Staphylococcus	 epidermis	 (Table	 2).	 The	 novel	 Schiff	 base	
compounds	 of	 amoxicillin	with	 compounds	1,	6,	7,	9,	10,	11	
and	 13	 found	 to	 be	 possessing	 extra‐ordinary	 bioactivity	
against	 Pseudomonas	 aeruginosa	 (Table	 2).	 Derivatives	 of	
amoxicillin	with	carbonyl	compounds	2,	4,	5,	7,	9,	10,	and	11	
found	to	be	having	more	bioactivity	against	E.	coli	(Table	2).	
	
4.	Conclusion	
	
Imine	 derivative	 compounds	 derived	 from	 amoxicillin	
trihydrate	 were	 synthesized	 and	 structurally	 characterized	
using	 spectroscopic	 techniques.	 The	 synthetic	 route	 started	
with	 reaction	 between	 amoxicillin	 and	 different	 carbonyl	
compounds;	aldehydes	and	ketones	in	ethanol	as	solvent.	The	
imine	 derivatives	 containing	 amoxicillin	 moiety	 have	 been	
evaluated	 in	 vitro	 for	 their	 antimicrobial	 activities	 against	
bacterial	 strains	 (Staphylococcus	 epidermidis,	 Pseudomonas	
aeruginosa,	 Escherichia	 coli)	 microorganisms	 at	 different	
concentrations	(1×10‐1,	1×10‐3,	1×10‐5	and	1×10‐7	M).	
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Table	2.	Antimicrobial	activities	of	the	prepared	compounds	*.	
Compound	 S.	Epidermis	 P.	aeruginosa	 E.	coli	
Concentration	 Concentration Concentration	
1×10‐1	
mg/mL	
1×10‐3	
mg/mL	
1×10‐5	
mg/mL	
1×10‐7	
mg/mL	
1×10‐1	
mg/mL	
1×10‐3	
mg/mL	
1×10‐5	
mg/mL	
1×10‐7	
mg/mL	
1×10‐1	
mg/mL	
1×10‐3	
mg/mL	
1×10‐5	
mg/mL	
1×10‐7	
mg/mL	
1	 27	 23	 20	 17 25 22 17 13 22 17	 13	 8
2	 22	 17	 14	 10 21 17 14 10 25 20	 16	 13
3	 27	 22	 18	 15	 22	 17	 11	 6	 19	 15	 12	 9	
4	 21	 17	 14	 9	 23	 16	 10	 5	 24	 18	 15	 11	
5	 28	 24	 19	 15	 21	 16	 12	 7	 25	 22	 17	 14	
6	 31	 28	 23	 19 27 19 12 6 21 17	 14	 10
7	 24	 20	 17	 13 28 23 17 11 24 21	 16	 12
8	 23	 18	 11	 7	 20 15 11 7 17 13	 10	 6
9	 35	 31	 27	 24 35 29 26 22 31 28	 23	 17
10	 34	 29	 26	 23 34 30 25 23 34 29	 25	 21
11	 28	 25	 21	 16 30 26 23 20 31 28	 23	 19
12	 30	 27	 23	 20 18 15 11 6 29 26	 24	 20
13	 29	 24	 20	 17	 26	 23	 19	 14	 21	 18	 13	 7	
14	 23	 20	 16	 13	 22	 17	 13	 10	 22	 17	 14	 9	
Amoxicillin	 22	 17	 13	 8	 20 16 11 6 15 14	 11	 7
*	Method	used:	Disc	diffusion	method,	Culture	media	used:	Muller	Hinton	agar	media,	Incubation	time:	20	hr,	Incubation	temperature:	37±1°C.	
	
	
The	 results	 showed	 that	 majority	 of	 the	 novel	 imine	
derivatives	 have	 good	 antibacterial	 activity	 compared	 to	 the	
parent	drug.	
	
Acknowledgement	
	
We	 are	 thankful	 to	 Institute	 of	 Chemical	 Sciences,	
Bahauddin	 Zakariya	 University,	 Multan,	 60800	 Pakistan	 for	
financial	support.	
	
References	
	
[1]. Hay,	S.	I.;	Battle,	K.	E.;	Pigott,	D.	M.;	Smith,	D.	L.;	Moyes,	C.	L.;	Bhatt,	S.;	
Brownstein,	J.	S.;	Collier,	N.;	Myers,	M.	F.;	George,	D.	B.;	Gething,	P.	W.	
Trans.	R.	Soc.	Lond.	B:	Biol.	Sci.	2013,	368,	20120250,	1‐11.		
[2]. Aoki,	H.;	Okuhara,	M.	Annu.	Rev.	Microbiol.	1980,	34,	159‐181.		
[3]. Kemal,	 U.;	 Palabiyik,	 L.;	 Karacan,	 E.;	 Feyyaz,	 O.	 Turk	 J.	 Pharm.	 Sci.	
2008,	5,	1‐16.		
[4]. Qin,	W.;	Panunzio,	M.;	Biondi,	S.	Antibiotics	2014,	3,	193‐215.		
[5]. Utsui,	 Y.;	 Inoue,	 M.;	 Mitsuhashi,	 S.	 Antimicrob.	 Agents	 Chemother.	
1987,	31,	1085‐1092.		
[6]. Sanders,	C.	C.;	Sanders,	W.	E.	Clin.	Infect.	Dis.	1992,	15,	824‐839.		
[7]. Leemans,	E.;	Fisher,	J.;	Mobashery,	S.;	Marinelli,	F.;	Genilloud,	O.	Eds.;	
Springer	Berlin	Heidelberg,	2014;	pp	59‐84.		
[8]. Acuna,	C.;	Rabasseda,	X.	Drugs	Today	2001,	37,	193‐210.		
[9]. Kaur,	S.	P.;	Rao,	R.;	Nanda,	S.	Int.	J.	Pharm.	Pharm.	Sci.	2011,	3,	30‐37.		
[10]. Nazir,	F.;	Bukhari,	I.	H.;	Arif,	M.;	Riaz,	M.;	Naqvi,	S.	A.	R.;	Bokhari,	T.	H.;	
Jamal,	M.	A.	Int.	J.	Curr.	Pharm.	Res.	2013,	5,	40‐47.		
[11]. Bijev,	A.	T.;	Hung,	V.	Arzneimitt.	Forsch.	2001,	51,	667‐672.		
[12]. Tomi,	I.	H.	R.;	Abdullah,	A.	H.;	Al‐Daraji,	A.	H.	R.;	Abbass,	S.	A.	R.	Eur.	J.	
Chem.	2013,	4(2),	153‐156.		
[13]. Joshi,	S.	Int.	J.	Pharm.	Biol.	Sci.	2011,	2,	240‐250.		
[14]. Joshi,	S.;	Pawar,	V.;	Uma,	V.	Res.	J.	Pharm.	Biol.	Chem.	Sci.	2011,	2,	61‐
70.		
[15]. Al‐Noor,	T.	H.;	Aziz,	M.	R.;	AL‐Jeboori,	A.	T.	J.	Chem.	Pharm.	Res.	2014,	
6,	1225‐1231.		
[16]. Abdel‐Rahman,	 A.	 A.	 H.;	 Abdel‐Megied,	 A.	 E.	 ‐S.;	 Hawata,	 M.	 A.	 A.;	
Kasem,	E.	R.;	Shabanm,	M.	T.	Monatsh.	Chem.	2007,	138,	889‐897.		
[17]. Azevedo,	C.	M.	P.	G.,	PhD	Thesis,	2012,	http://hdl.	handle.net/10216	
/73974	
[18]. Hameed,	A.;	Shafiq,	Z.;	Yaqub,	M.;	Hussain,	M.;	Hussain,	M.	A.;	Afzal,	
M.;	 Tahir,	 M.	 N.;	 Naseer,	 M.	 M.	 New	 J.	 Chem.	 2015,	 DOI:	
10.1039/C5NJ01879J.	
[19]. Chohan,	Z.	H.;	Arif,	M.;	Shafiq,	Z.;	Yaqub,	M.;	Supuran,	C.	T.	J.	Enzyme	
Inhib.	Med.	Chem.	2006,	21(1),	95‐103.		
[20]. Hussain	A.;	Shafiq,	Z.;	Tahir,	M.	N.;	Yaqub,	M.	Acta	Crytallog.	E	2010,	
66(8),	o1888‐o1888.		
[21]. Hameed,	A.;	Khan,	K.	M.;	Zehra,	S.	T.;	Ahmed,	R.;	Shafiq,	Z.;	Bakht,	S.	
M.;	 Yaqub,	 M.;	 Hussain,	 M.;	 de	 Leon,	 A.	 de	 la	 V.;	 Furtmann,	 N.;	
Bajorath,	J.;	Shad,	H.	A.;	Tahir,	M.	N.;	Iqbal,	J.	Bioorg.	Chem.	2015,	61,	
51‐57.		
[22]. Jodeh,	 S.;	 Stati,	 H.;	 Haddad,	 M.;	 Renno,	 T.;	 Zaid,	 A.;	 Jaradat,	 N.;	
Kharoaf,	M.	Eur.	J.	Chem.	2012,	3(4),	480‐484.		
[23]. El‐Sawi,	E.	A.;	Mostafa,	T.	B.;	Radwan,	H.	A.	Eur.	J.	Chem.	2011,	2(4),	
539‐543.		
	
	
